Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Manufacturing has been the key factor limiting rollout of vaccination during the COVID-19 pandemic, requiring rapid development and large-scale implementation of novel manufacturing technologies. This article is protected by copyright. All rights reserved.

Original publication

DOI

10.1002/bit.27945

Type

Journal article

Journal

Biotechnol Bioeng

Publication Date

29/09/2021

Keywords

Adenovirus, Distributed manufacturing, Vaccine